Current and historical daily PE Ratio for Shijiazhuang Yiling Pharmaceutical Co Ltd (
SZSE:002603
) from 2011 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shijiazhuang Yiling Pharmaceutical stock (SZSE:002603) PE ratio as of Jun 07 2024 is 65.4.
More Details
Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) PE Ratio (TTM) Chart
Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1200
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Shijiazhuang Yiling Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-07 | 65.4 | 2024-03-29 | 74.2 |
| 2024-06-06 | 65.3 | 2024-03-28 | 74.2 |
| 2024-06-05 | 66.8 | 2024-03-27 | 24.9 |
| 2024-06-04 | 66.1 | 2024-03-26 | 25.1 |
| 2024-06-03 | 65.5 | 2024-03-25 | 25.2 |
| 2024-05-31 | 66.8 | 2024-03-22 | 25.7 |
| 2024-05-30 | 65.9 | 2024-03-21 | 26.3 |
| 2024-05-29 | 66.9 | 2024-03-20 | 26.5 |
| 2024-05-28 | 66.8 | 2024-03-19 | 26.5 |
| 2024-05-27 | 67.7 | 2024-03-18 | 26.9 |
| 2024-05-24 | 68.1 | 2024-03-15 | 26.6 |
| 2024-05-23 | 69.0 | 2024-03-14 | 26.6 |
| 2024-05-22 | 70.5 | 2024-03-13 | 26.5 |
| 2024-05-21 | 70.4 | 2024-03-12 | 26.7 |
| 2024-05-20 | 71.3 | 2024-03-11 | 26.1 |
| 2024-05-17 | 71.4 | 2024-03-08 | 25.7 |
| 2024-05-16 | 71.7 | 2024-03-07 | 25.6 |
| 2024-05-15 | 72.9 | 2024-03-06 | 26.3 |
| 2024-05-14 | 73.3 | 2024-03-05 | 26.5 |
| 2024-05-13 | 72.3 | 2024-03-04 | 26.9 |
| 2024-05-10 | 71.0 | 2024-03-01 | 26.6 |
| 2024-05-09 | 72.0 | 2024-02-29 | 26.5 |
| 2024-05-08 | 70.6 | 2024-02-28 | 26.2 |
| 2024-05-07 | 71.6 | 2024-02-27 | 26.5 |
| 2024-05-06 | 71.3 | 2024-02-26 | 26.3 |
| 2024-04-30 | 69.2 | 2024-02-23 | 26.3 |
| 2024-04-29 | 70.0 | 2024-02-22 | 26.3 |
| 2024-04-26 | 72.0 | 2024-02-21 | 26.2 |
| 2024-04-25 | 71.5 | 2024-02-20 | 26.3 |
| 2024-04-24 | 70.9 | 2024-02-19 | 25.7 |
| 2024-04-23 | 71.2 | 2024-02-08 | 25.6 |
| 2024-04-22 | 70.8 | 2024-02-07 | 25.2 |
| 2024-04-19 | 71.0 | 2024-02-06 | 24.9 |
| 2024-04-18 | 71.5 | 2024-02-05 | 23.2 |
| 2024-04-17 | 72.4 | 2024-02-02 | 23.8 |
| 2024-04-16 | 70.5 | 2024-02-01 | 24.5 |
| 2024-04-15 | 72.2 | 2024-01-31 | 24.3 |
| 2024-04-12 | 72.2 | 2024-01-30 | 26.0 |
| 2024-04-11 | 72.9 | 2024-01-29 | 27.1 |
| 2024-04-10 | 73.6 | 2024-01-26 | 27.5 |
| 2024-04-09 | 74.7 | 2024-01-25 | 27.5 |
| 2024-04-08 | 73.6 | 2024-01-24 | 27.0 |
| 2024-04-03 | 74.5 | 2024-01-23 | 26.9 |
| 2024-04-02 | 74.3 | 2024-01-22 | 26.7 |
| 2024-04-01 | 75.4 | 2024-01-19 | 27.7 |
Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Shijiazhuang Yiling Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE1000015S0
Share Class Description:
SZSE:002603: Class ACompare
Compare
Traded in other countries / regions
002603.China IPO Date
2011-07-28Description
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers